World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on July 30, 2026

Jul. 30, 2026

Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

Indeterminate GlobeNewswire

Jul. 30, 2026

Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Jul. 30, 2026

MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients

Indeterminate GlobeNewswire

Jul. 30, 2026

GigaCloud Technology Inc to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Immutep Quarterly Activities Report Q4 FY26

Indeterminate GlobeNewswire

Jul. 30, 2026

CorVascular Launches ASUS Handheld Ultrasound Portfolio for Vascular Specialists at SVU 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Enlivex Treasury Portfolio Update: RAIN Trading Volume Reaches $860MM, 622% Month-Over-Month Growth in July vs June

Indeterminate GlobeNewswire

Jul. 30, 2026

electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

Indeterminate GlobeNewswire

Jul. 30, 2026

Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Jul. 30, 2026

SIGA to Host Business Update Call on August 6, 2026, Following Release of Second-Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Jul. 30, 2026

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Jul. 30, 2026

Tvardi Therapeutics Selects Ulcerative Colitis as Initial Indication for TTI-109

Indeterminate GlobeNewswire

Jul. 30, 2026

PharmAla Issues Q3 Financial Statements and AGM Update

Indeterminate GlobeNewswire

Jul. 30, 2026

InflaRx to Report Second Quarter 2026 Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 30, 2026

Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing

Indeterminate GlobeNewswire

Jul. 30, 2026

Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update

Indeterminate GlobeNewswire